KEGG   DRUG: Opicinumab
Entry
D11767                      Drug                                   
Name
Opicinumab (USAN/INN)
Formula
C6406H9896N1708O2012S44
Exact mass
144351.2263
Mol weight
144440.30
Sequence
(Heavy chain)
EVQLLESGGG LVQPGGSLRL SCAASGFTFS AYEMKWVRQA PGKGLEWVSV IGPSGGFTFY
ADSVKGRFTI SRDNSKNTLY LQMNSLRAED TAVYYCATEG DNDAFDIWGQ GTTVTVSSAS
TKGPSVFPLA PSSKSTSGGT AALGCLVKDY FPEPVTVSWN SGALTSGVHT FPAVLQSSGL
YSLSSVVTVP SSSLGTQTYI CNVNHKPSNT KVDKKVEPKS CDKTHTCPPC PAPELLGGPS
VFLFPPKPKD TLMISRTPEV TCVVVDVSHE DPEVKFNWYV DGVEVHNAKT KPREEQYNSA
YRVVSVLTVL HQDWLNGKEY KCKVSNKALP APIEKTISKA KGQPREPQVY TLPPSRDELT
KNQVSLTCLV KGFYPSDIAV EWESNGQPEN NYKTTPPVLD SDGSFFLYSK LTVDKSRWQQ
GNVFSCSVMH EALHNHYTQK SLSLSPG
(Light chain)
DIQMTQSPAT LSLSPGERAT LSCRASQSVS SYLAWYQQKP GQAPRLLIYD ASNRATGIPA
RFSGSGSGTD FTLTISSLEP EDFAVYYCQQ RSNWPMYTFG QGTKLEIKRT VAAPSVFIFP
PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS QESVTEQDSK DSTYSLSSTL
TLSKADYEKH KVYACEVTHQ GLSSPVTKSF NRGEC
(Disulfide bridge: H22-H96, H145-H201, H221-L215, H227-H'227, H230-H'230, H262-H322, H368-H426, H'22-H'96, H'145-H'201, H'221-L'215, H'262-H'322, H'368-H'426, L23-L88, L135-L195, L'23-L'88, L'135-L'195)
  Type
Peptide
Efficacy
Demyelinating disease agent
  Type
Monoclonal antibody
Comment
Treatment of multiple sclerosis
Target
LINGO1 [HSA:84894] [KO:K23533]
Brite
Target-based classification of drugs [BR:br08310]
 Not elsewhere classified
  Cellular process
   Membrane trafficking
    LINGO1
     D11767  Opicinumab (USAN/INN)
Other DBs
CAS: 1422268-07-2
PubChem: 405226633
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system